Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Apoptosis: A target for anticancer therapy with novel cyanopyridines
Magda M. F. Ismail, Amel M. Farrag, Marwa F. Harras, et al.
Bioorganic Chemistry (2019) Vol. 94, pp. 103481-103481
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Piezo1 initiates platelet hyperreactivity and accelerates thrombosis in hypertension
Weiyu Zhao, Zeliang Wei, Guang Xin, et al.
Journal of Thrombosis and Haemostasis (2021) Vol. 19, Iss. 12, pp. 3113-3125
Closed Access | Times Cited: 43
Advances in the Application of Acetonitrile in Organic Synthesis since 2018
Pinyong Zhong, Linjun Zhang, Nianhua Luo, et al.
Catalysts (2023) Vol. 13, Iss. 4, pp. 761-761
Open Access | Times Cited: 20
Synthesis, properties, and application of the new nanocatalyst of double layer hydroxides in the one-pot multicomponent synthesis of 2-amino-3-cyanopyridine derivatives
Sarieh Momeni, Ramin Ghorbani‐Vaghei
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Synthesis and Insecticidal Evaluation of 3,5‐Dicyanopyridines Against Cotton Aphids via Microwave‐Assisted Multicomponent Reactions
Hany M. Abd El‐Lateef, Mai M. Khalaf, Mohamed Gouda, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 4
Closed Access | Times Cited: 6
New molecular hybrids integrated with quinoxaline and pyrazole structural motifs: VGFR2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108182-108182
Closed Access
Insights into Novel Arylazopyrazolo[1,5-a]pyrimidines as Promising MurA Inhibitors and Antibiofilm Candidates: Design, Synthesis, Antimicrobial Evaluation, and Molecular Docking
Omkulthom Al Kamaly, Amel S. Younes, Mona H. Ibrahim, et al.
ACS Omega (2025)
Open Access
The Role of Copper Ions in Mediating the Anti‐Cancer Effects Using Nanomaterials
Irfan Mehmud, Song Wu, Shaohua Zhang
Advanced Therapeutics (2025)
Closed Access
Novel azo pyridone dyes based on dihydropyrimidinone skeleton: Synthesis, DFT study and anticancer activity
Julijana Tadić, Jelena Lađarević, Željko Vitnik, et al.
Dyes and Pigments (2020) Vol. 187, pp. 109123-109123
Open Access | Times Cited: 36
Novel quinoxaline-based VEGFR-2 inhibitors to halt angiogenesis
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
Bioorganic Chemistry (2023) Vol. 139, pp. 106735-106735
Closed Access | Times Cited: 10
Design and synthesis of novel chloropyridazine hybrids as promising anticancer agents acting by apoptosis induction and PARP-1 inhibition through a molecular hybridization strategy
Norhan A. Abdelrahman, Ahmed A. Al‐Karmalawy, Maiy Jaballah, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 3, pp. 981-997
Closed Access | Times Cited: 3
Nicotinonitrile-derived apoptotic inducers: Design, synthesis, X-ray crystal structure and Pim kinase inhibition
Shaimaa M. Aboukhatwa, Amera O. Ibrahim, Hiroshi Aoyama, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106126-106126
Closed Access | Times Cited: 16
Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
New cyanopyridine-based scaffold as PIM-1 inhibitors and apoptotic inducers: Synthesis and SARs study
Amel M. Farrag, Mona H. Ibrahim, Ahmed B. M. Mehany, et al.
Bioorganic Chemistry (2020) Vol. 105, pp. 104378-104378
Closed Access | Times Cited: 24
Utilization of cyanopyridine in design and synthesis of first-in-class anticancer dual acting PIM-1 kinase/HDAC inhibitors
Amr K.A. Bass, El-Shimaa M. Nageeb, Mona S. El‐Zoghbi, et al.
Bioorganic Chemistry (2021) Vol. 119, pp. 105564-105564
Closed Access | Times Cited: 22
Discovery of new cyanopyridine/chalcone hybrids as dual inhibitors of EGFR/BRAFV600E with promising antiproliferative properties
Hesham A. Abou‐Zied, Eman A. M. Beshr, Hesham A. M. Gomaa, et al.
Archiv der Pharmazie (2022) Vol. 356, Iss. 4
Closed Access | Times Cited: 15
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAFV600E Inhibitory Pathways
Lamya H. Al-Wahaibi, Hesham A. Abou‐Zied, Mohamed Hisham, et al.
Molecules (2023) Vol. 28, Iss. 18, pp. 6586-6586
Open Access | Times Cited: 8
A review: Biological activities of novel cyanopyridine derivatives
Yurou Wu, Tao Wu, Yong Huang
Archiv der Pharmazie (2023) Vol. 356, Iss. 7
Closed Access | Times Cited: 7
Preparation, DFT calculations, docking studies, antioxidant, and anticancer properties of new pyrazole and pyridine derivatives
Zineddine Zebbiche, Güldeniz Şekerci, Houssem Boulebd, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 9
Closed Access | Times Cited: 13
The anti-breast cancer activity of indeno[1,2-b]pyridin-5-one and their hydrazonal precursors endowed with anti-CDK-2 enzyme activity
Sami A. Al‐Hussain, Thoraya A. Farghaly, Mona H. Ibrahim, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136692-136692
Closed Access | Times Cited: 7
3-Cyano-2-oxa-pyridines: a promising template for diverse pharmacological activities
Amr K.A. Bass, Elshimaa M. N. Abdelhafez, Mona S. El‐Zoghbi, et al.
Journal of advanced Biomedical and Pharmaceutical Sciences (2021) Vol. 4, Iss. 2, pp. 81-86
Open Access | Times Cited: 16
Development of novel cyanopyridines as PIM-1 kinase inhibitors with potent anti-prostate cancer activity: Synthesis, biological evaluation, nanoparticles formulation and molecular dynamics simulation
Mona H. Ibrahim, Marwa F. Harras, Shaimaa K. Mostafa, et al.
Bioorganic Chemistry (2022) Vol. 129, pp. 106122-106122
Closed Access | Times Cited: 11
Synthesis, molecular modeling Insights, and anticancer assessment of novel polyfunctionalized Pyridine congeners
Mohamed G. Abouelenein, Ahmed A. El‐Rashedy, Hanem M. Awad, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106910-106910
Closed Access | Times Cited: 6
Novel quinoxaline-3-propanamides as VGFR-2 inhibitors and apoptosis inducers
Magda M. F. Ismail, Taghreed Z. Shawer, Rabab S. Ibrahim, et al.
RSC Advances (2023) Vol. 13, Iss. 45, pp. 31908-31924
Open Access | Times Cited: 6
Dual EGFR/VEGFR2 inhibitors and apoptosis inducers: Synthesis and antitumor activity of novel pyrazoline derivatives
Omkulthom Al Kamaly, Najla Altwaijry, Rehab Sabour, et al.
Archiv der Pharmazie (2020) Vol. 354, Iss. 4
Closed Access | Times Cited: 17
Aminopyridone-linked benzimidazoles: a fragment-based drug design for the development of CDK9 inhibitors
Ebtehal M. Husseiny, Hamada S. Abulkhair, Sanadelaslam SA El-Hddad, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1213-1232
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top